- P-ISSN 1225-0163
- E-ISSN 2288-8985
- Log In/Sign Up
- P-ISSN1225-0163
- E-ISSN2288-8985
- SCOPUS, ESCI, KCI
Article Detail
Home > Article Detail
Development of Jaspine B analysis using LC-MS/MS and its application: Dose-independent pharmacokinetics of Jaspine B in rats
Analytical Science and Technology / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
2021, v.34 no.2, pp.37-45
https://doi.org/10.5806/AST.2021.34.2.37
(Kyungpook National University)
(Kyungpook National University)
(College of Pharmacy, Dankook University,)
(College of Pharmacy, Dankook University)
(College of Pharmacy, Ajou University)
(College of Pharmacy, Dankook University)
(Kyungpook National University)
(College of Pharmacy, Dankook University,)
(College of Pharmacy, Dankook University)
(College of Pharmacy, Ajou University)
(College of Pharmacy, Dankook University)
Im-Sook,
S.
, Ji-Hyeon,
J.
, Dong,
Y.
L.
, Chul,
H.
L.
, Dongjoo,
L.
, &
Min-Koo,
C.
(2021). Development of Jaspine B analysis using LC-MS/MS and its application: Dose-independent pharmacokinetics of Jaspine B in rats. Analytical Science and Technology, 34(2), 37-45, https://doi.org/10.5806/AST.2021.34.2.37
- Downloaded
- Viewed
Abstract
A rapid and simple LC-MS/MS analytical method in determining Jaspine B has been developed and validated in rat plasma. The standard curve value was 25 – 5000 ng/mL and the linearity, inter-day and intra-day accuracy and precision were within 15.0 % of relative standard deviation (RSD). The mean recoveries of Jaspine B ranged from 87.5 % to 91.2 % with less than 3.70 % RSD and the matrix effects ranged from 91.1 % to 108.2 % with less than 2.6 % RSD. The validated LC-MS/MS analytical method of Jaspine B was successfully applied to investigate the dose-escalated pharmacokinetic study of Jaspine B in rats following an intravenous injection of Jaspine B at a dose range of 1 – 10 mg/kg. The initial plasma concentrations and area under plasma concentration curves showed a good correlation with intravenous Jaspine B dose, indicating the dose independent pharmacokinetics of Jaspine B in rats. In conclusion, this analytical method for Jaspine B can be easily applied in the bioanalysis and pharmacokinetic studies of Jaspine B, including its administration at multiple therapeutic doses, or for making pharmacokinetic comparisons for the oral formulations of Jaspine B in small experimental animals as well as in vivo pharmacokinetic–pharmacodynamic correlation studies.
- keywords
- jaspine B, liquid chromatography-tandem mass spectrometry, pharmacokinetics, rat, dose escalation
Reference
1
1. S. O. Lee, J. S. Kim, M. S. Lee and H. J. Lee, BMC Cancer, 16, 701 (2016).
2
2. S. A. Morad and M. C. Cabot, Nature Reviews Cancer, 13(1), 51-65 (2013).
3
3. D. Shida, K. Takabe, D. Kapitonov, S. Milstien and S. Spiegel, Current Drug Targets, 9(8), 662-673 (2008).
4
4. M. Bektas, P. S. Jolly, C. Muller, J. Eberle, S. Spiegel and C. C. Geilen, Oncogene, 24(1), 178-187 (2005).
5
5. K. J. French, R. S. Schrecengost, B. D. Lee, Y. Zhuang, S. N. Smith, J. L. Eberly, J. K. Yun and C. D. Smith, Cancer Research, 63(18), 5962-5969 (2003).
6
6. K. R. Johnson, K. Y. Johnson, H. G. Crellin, B. Ogretmen, A. M. Boylan, R. A. Harley and L. M. Obeid, Journal of Histochemistry and Cytochemistry, 53(9), 1159-1166(2005).
7
7. S. Sobue, T. Iwasaki, C. Sugisaki, K. Nagata, R. Kikuchi, M. Murakami, A. Takagi, T. Kojima, Y. Banno, Y. Akao, Y. Nozawa, R. Kannagi, M. Suzuki, A. Abe, T. Naoe and T. Murate, Leukemia, 20(11), 2042-2046 (2006).
8
8. B. Haefner, Drug Discovery Today, 8(12), 536-544(2003).
9
9. I. Kuroda, M. Musman, I. I. Ohtani, T. Ichiba, J. Tanaka, D. G. Gravalos and T. Higa, Journal of Natural Products, 65(10), 1505-1506 (2002).
10
10. Y. Yoshimitsu, S. Oishi, J. Miyagaki, S. Inuki, H. Ohno and N. Fujii, Bioorganic & Medicinal Chemistry, 19(18), 5402-5408 (2011).
11
11. Y. Salma, E. Lafont, N. Therville, S. Carpentier, M. J. Bonnafe, T. Levade, Y. Genisson and N. Andrieu-Abadie, Biochemical Pharmacology, 78(5), 477-485 (2009).
12
12. H. Yoo, Y. S. Lee, S. Lee, S. Kim and T. Y. Kim, Phytotherapy Research, 26(12), 1927-1933 (2012).
13
13. B. A. Stoica, V. A. Movsesyan, P. M. Lea and A. I. Faden, Molecular and Cellular Neuroscience, 22(3), 365-382(2003).
14
14. V. Garcia, P. Le Faouder, A. Dupuy, T. Levade, S. Ballereau and Y. Genisson, Chemistry & Biodiversity, 12(7), 1115-1125 (2015).
15
15. F. Cingolani, F. Simbari, J. L. Abad, M. Casasampere, G. Fabrias, A. H. Futerman and J. Casas, Journal of Lipid Research, 58(8), 1500-1513 (2017).
16
16. J. Lee, K. Choi, M. Kwon, D. Lee, M. K. Choi and I. S. Song, Journal of Life Science, 26(12), 101-109 (2016).
17
17. Y. Kwon, J. Song, H. Bae, W. J. Kim, J. Y. Lee, G. H. Han, S. K. Lee and S. Kim, Marine Drugs, 13(2), 824-837 (2015).
18
18. M. Kwon, D. Y. Lim, C. H. Lee, J. H. Jeon, M. K. Choi and I. S. Song, Pharmaceutics, 12(9) 882 (2020).
19
19. J. H. Jeon, J. Lee, M. K. Choi and I. S. Song, Archives of Pharmacal Research, 43(12), 1335-1346 (2020).
Other articles from this issue
- Development of Jaspine B analysis using LC-MS/MS and its application: Dose-independent pharmacokinetics of Jaspine B in rats
- Gliclazide compatibility with some common chemically reactive excipients; using different analytical techniques
- A preliminary study of semi-quantitative, comparative evaluation of split or half fingerprints using Densitometric Image Analysis (DIA) - Inter-analyst differences for split or half fingerprints -
- Development and validation of a qualitative GC-MS method for THCCOOH in urine using injection-port derivatization
- Determination of cut-off value by receiver operating characteristic curve of norquetiapine and 9-hydroxyrisperidone concentrations in urine measured by LC-MS/MS
- Development of a nanoparticle multi-generator for assessment of inhalation hazard
- more
Recommanded Articles
This website recommended the use the Chrome browser for journal website.